Glucagon-like Peptide-1 Receptor Agonist Liraglutide Inhibits Endothelin-1 in Endothelial Cell by Repressing Nuclear Factor-Kappa B Activation

The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells

(2012) Aya Shiraki et al.   ATHEROSCLEROSIS

A Glucagon-Like Peptide-1 Analog Reverses the Molecular Pathology and Cardiac Dysfunction of a Mouse Model of Obesity

(2012) Mohammad Hossein Noyan-Ashraf et al.   CIRCULATION

Potential Pathogenic Inflammatory Mechanisms of Endothelial Dysfunction Induced by Type 2 Diabetes Mellitus

(2012) Anna-Maria Kampoli et al.   CURRENT PHARMACEUTICAL DESIGN

A comparison of currently available GLP-1 receptor agonists for the treatment of type 2 diabetes

(2012) Eduard Montanya   EXPERT OPINION ON PHARMACOTHERAPY

Lectin-like Oxidized Low-density Lipoprotein Receptor-1 (LOX-1) and Cardiac Fibroblast Growth

(2012) Xianwei Wang et al.   HYPERTENSION

Role of NF-κB and p38 MAPK activation in mediating angiotensin II and endothelin-1-induced stimulation in leptin production and cardiomyocyte hypertrophy

(2012) Venkatesh Rajapurohitam et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Role of the vascular endothelium and plaque in acute ischemic stroke

(2012) J. A. Madden   NEUROLOGY

Diabetic Vascular Disease: Characteristics of Vascular Disease Unique to the Diabetic Patient

(2012) Gary W. Gibbons et al.   Seminars in Vascular Surgery

Oxidative Stress and Lectin-Like Ox-LDL-Receptor LOX-1 in Atherogenesis and Tumorigenesis

(2011) Jingjun Lu et al.   ANTIOXIDANTS & REDOX SIGNALING

A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model

(2011) Tracey Gaspari et al.   Diabetes & Vascular Disease Research

Novel IκB kinase inhibitors for treatment of nuclear factor-κB-related diseases

(2011) Jun-Ichi Suzuki et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

How mental stress affects endothelial function

(2011) Noboru Toda et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4

(2010) M. Arakawa et al.   DIABETES

RETRACTED ARTICLE: A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells

(2010) Y. Hattori et al.   DIABETOLOGIA

Endothelin-1 Release and Stimulation of the Inflammatory Cascade

(2010) Karina W. Davidson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor

(2010) Ö. Erdogdu et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry

(2010) Benjamin Bonavida et al.   NITRIC OXIDE-BIOLOGY AND CHEMISTRY

Cardiovascular Biology of Interleukin-6

(2009) Mahinda Abeywardena et al.   CURRENT PHARMACEUTICAL DESIGN

GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice

(2009) M. H. Noyan-Ashraf et al.   DIABETES

Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

(2008) Kiwon Ban et al.   CIRCULATION

PPARα activators upregulate eNOS activity and inhibit cytokine-induced NF-κB activation through AMP-activated protein kinase activation

(2008) Toshie Okayasu et al.   LIFE SCIENCES